Introduction: Dyslipidemia, particularly elevated low-density lipoprotein cholesterol (LDL-C),
is a key risk factor for atherosclerotic cardiovascular disease (ASCVD), and lipid-lowering …

Introduction: Cholesterol lowering treatment is mainly based on statins eventually
associated to adjunctive drugs of different class such as ezetimibe. In the present review, we …

Previous studies have shown that fermentations can enhance the bioactivity and absorption
rate of soybean products. Fermented soybean products can alleviate hyperlipidemia and …

Introduction: Hypercholesterolemia is the main modifiable risk factor for atherosclerosis
progression and cardiovascular disease (CVD) development. Its pharmacological …

Background: Obesity, a sort of dietary imbalance, is one of the most frequently encountered
medical problems associated with many complications as hypertension, hyperlipidemia, and …

One of the main functions of the liver is to protect the organism against intoxication. The
endoplasmic reticulum of liver cells contains enzymes that protect the organism against an …

To study the hypolipidemic effect of a fermented seaweed polysaccharide on experimental
hyperlipidemic mice for Conducted a series of work. Algal polysaccharides can alleviate …

Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled,
multicenter study to assess the effect of evolocumab on cognitive function in patients with …

Objectives: The objectives of this evidential review is to conceptualize the ability of
Evolocumab in combination with statins for reducing low density lipoprotein concentrations …

Circulating LDL-cholesterol (LDL-C) concentration is a well established, modifiable risk
factor for atherosclerosis [1]. According to this, decrements in serum LDL-C levels are …